Navigation Links
Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
Date:1/25/2008

le period of the prior fiscal year, and $2.1 million in bone void filling products royalties from Orthovita, Inc., a 19% increase from $1.8 million in the prior fiscal year six-month period.

Earnings Per Share. The Company reported earnings per share of $0.19 for the six-months ended December 31, 2007 compared to $0.24 diluted earnings per share for the six months ended December 31, 2006. Earnings per share included pre-tax charges of $3.0 million, or $0.16 per share tax-effected, for the acceleration of stock awards and approximately $325,000, or $0.02 per share tax-effected, of charges related to the discontinuation of the Company's embolic protection platform, incurred during the first quarter of fiscal 2008. Adjusted earnings per share, excluding these charges, was $0.36 for the six months ending December 31, 2007, a 50% increase over the prior year six-month period.

In the six-month period ended December 31, 2007, the total tax-effected impact on earnings per share of equity compensation expense was $0.23, of which $0.16 related to the acceleration of stock awards and $0.08 related to equity compensation expense prior to the acceleration, equity compensation from current year equity grants as well as a mark-to-market adjustment on Stock Appreciation Rights. The tax-effected impact on earnings per share of equity compensation expense was $0.09 in the six-month period ended December 31, 2006.

The following chart summarizes the Company's results for the six months ended December 31, 2007, compared to its results for the comparable period in the prior fiscal year. See attached schedules for a detailed reconciliation between the non-GAAP and reported GAAP results.

Six Months Year over

Ended December 31, Year %

($ millions, except per share data) 2007 2006 Change

Data As Reported:

Net Sa
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
3. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
4. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
5. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
6. Kensey Nash Announces $25 Million Stock Repurchase Program
7. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
8. WellPoint Reports Fourth Quarter and Full Year 2007 Results
9. Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance
10. TeamStaff Reports Fourth Quarter and Fiscal 2007 Results; Posts Fourth Quarter Income From Operations
11. Health care reform and 2008 elections: New reports examine candidates plans, publics views
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Children who swallow high-powered magnets often need surgery and ... a new study. The researchers, from the Louisiana ... more than 79 percent of children who swallowed very ... procedure, in which a tube containing a camera is ... these cases can be treated through observation or by ...
(Date:5/18/2013)... 18, 2013) The use of a smartphone ... according to new research presented today at Digestive ... days in advance of the procedure, includes dietary ... be taken at strict intervals. The better the ... see cancer and precancerous polyps in the colon. ...
(Date:5/18/2013)... In a May 14, 2013 article entitled ... Discovering Cancer Gene,” Fox News reported the movie star ... she carried a gene that doctors estimated gave her ... 50 percent risk of ovarian cancer (go to: goo.gl/5JHBP). ... 2013 with a blog post entitled “A Patient’s Journey: ...
(Date:5/18/2013)... 18, 2013 Today, Zane Benefits, ... agents’ role in Marketplaces . Zane Benefits, which ... sponsored health benefits, is the leader in health ... health reimbursement arrangements . , According to Zane ... Services (HHS) recently released a much-anticipated statement and ...
(Date:5/18/2013)... Serena Gordon HealthDay Reporter , , FRIDAY, May 17 ... students sometimes binge drink, but new research shows that college ... on a weekly basis than are college men. ... alcohol that,s considered safe on a weekly basis is much ... for women versus 14 for men. But, there,s good reason ...
Breaking Medicine News(10 mins):Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:New smartphone application improves colonoscopy preparation 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3
... ten years since dolly’s birth and scientist are still doing ... ,Dolly offered hope to millions of sick and disabled people ... the world's first clone of an adult mammal. From then ... advanced and the cloning technique has been refined. Cloning is ...
... protein named menin – involved in tumor-suppression or cell-proliferation-suppressing ... which again affected blood sugar// regulation - researchers at ... ,In humans menin gene (Men1) mutation can lead ... 1 (MEN1) and this discovery also has implications for ...
... of oral clefting leaves some with psychological problems into adulthood. ... quality of life can be used to learn about the ... ,Oral clefting is one of the most common ... and can vary by age and type of clefting. Children ...
... Antibiotics - decreased cell death and heart attack injury ... cells//. ,A study with rapamycin - an ... by Virginia Commonwealth University researchers have revealed that heart ... protected by rapamycin. ,In the July issue ...
... botox – an anti-wrinkle treatment, Dr Frederic Meunier, ... a cure for motoneuronal diseases//. ,Researcher ... system in the body, which blocked the unnecessary ... motorneuron diseases. ,Motoneuronal diseases cause a ...
... stomach cancer who receive chemotherapy before and after surgery have ... published in Thursday‘s the 5th of July, New England Journal ... of death by at least a quarter, when compared to ... shrinking the tumors and thereby improved the survival without a ...
Cached Medicine News:Health News:Dolly Paves the Way for Exhaustive Stem Cell Research 2Health News:Menin Gene Mutation made Insulin Secreting Cells to Proliferate 2Health News:Learning the Value of Prevention and Treatment in Oral Clefting 2Health News:Antibiotic Proved Protective against Heart Tissue Damage and Cell Death – Research Find 2
(Date:5/16/2013)... 2013  PTC Therapeutics, Inc., today announced that it ... the U.S. Securities and Exchange Commission ("SEC") relating to ... The number of shares to be offered and the ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... book-running managers for the offering. Cowen and Company is ...
(Date:5/16/2013)... and SYDNEY , May 16, ... - ASX: HIN), a leading innovator of less invasive, miniaturized ... heart failure, today announced that CEO Doug Godshall ... Global Healthcare Conference at 11:00 a.m. EDT on Monday, May ... at the Sheraton New York Hotel. A live ...
(Date:5/16/2013)... , May 16, 2013 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the treatment ... Richard King , President and CEO, will present a ... Sheraton New York Hotel in New York ... 2013 at 9:30 a.m. ET/6:30 a.m. PT. The ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3
... well as humidification, try Flo-Mist™., ,Flo-Mist™, ... continuous medication nebulizer (CMN), engineered to deliver ... ml reservoir and jet flow design allow ... medication delivery at 25 ml/hr. Particles are ...
Nebulizer Custom Kit...
... Innovators in Anesthesia and Respiratory Products, ... quality medical devices for Anesthesia and Respiratory ... manufacture products that enhance the clinician's ability ... close attention to the bottom line. , ...
... nebulizer achieves optimum lung penetration for maximum ... is 1.04-1.10 µ at 6-8 LPM. Latex-free ... ,As the world leader in airway ... assurance of proven technology by offering top ...
Medicine Products: